Navigation Links
BioConvergence® Launches New Blog Aimed at Exploring Best Practices of Pharmaceutical and Biotechnology Industries
Date:6/6/2013

Bloomington, Indiana (PRWEB) June 06, 2013

BioConvergence, a contract service provider for pharmaceutical and biotechnology companies, recently launched a life sciences blog that addresses industry best practices.

The blog will cover a wide range of topics including testing and development, quality assurance, production, and supply chain management and security. The breadth of topics is well-suited to the organization, according to Lesli Stasiek, Global Manager of Business Development and Marketing:

“As a contract service provider, we produce unique solutions for life sciences organizations, regardless of their size or product development stage. Beyond this, our team members have gathered to BioConvergence from a wide variety of industry firms of different sizes, and many have worked with contract firms as clients themselves. These factors have given our team a broad perspective of the best practices realm that I know our readership will find both interesting and relevant.”

In addition to the articles supplied by BioConvergence, the company’s alliance partner Modality Solutions will also be contributing regularly.

Modality Solutions employs a Transport Simulation Laboratory of their design to simulate the rigors that pharmaceutical products are exposed to during transportation. BioConvergence then offers the support testing, quality assurance, and storage services needed to accommodate recommendations for formulation improvement.

Modality’s principals add over 100 years of combined life sciences experience to the nearly 500 years represented by the BioConvergence team. BioConvergence hopes that industry professionals, regardless of role, will “take advantage of this resource and gain greater visibility to industry trends and knowledge,” according to Stasiek.

To access BioConvergence’s corporate blog and additional resources, please visit http://blog.bioc.us.

About BioConvergence

BioConvergence is a contract service provider to the life sciences industry, offering outsourcing partnerships for formulation development, testing, production, and supply chain management. A women-owned and operated business headquartered in Bloomington, Indiana, BioConvergence has a team of over 50 members with nearly five centuries’ worth of combined experience in the life sciences industry. The company’s unique E-Transparency® System provides transparency and flexibility to its clients, along with superior, quality-driven outsourcing solutions. For more information, visit http://www.BioC.us.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10807732.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. BioConvergence® Celebrates Seventh Anniversary as a Life Sciences Contract Service Provider
2. BioMedical Life Systems, Inc. Launches New FDA Cleared Non-Prescription TENS Device
3. BellBrook Labs Launches Four New Turn-Key Methyltransferase Assay Kits
4. MAX Launches "Double HELIX" in Marylands Biotechnology Corridor
5. Salimetrics Launches a Faster, More Accurate, Salivary Melatonin Assay
6. Medical Concierge Travel International launches in Tandem with Leading Medical Cost Containment Company, EME International aimed at Self-Funded and Insurance Companies
7. Puritan Medical Products Launches New Series to Tell Customer Stories
8. Dr. Althauser Launches Ground-breaking Cavity Prevention Program That Can Lower Decay Rates by 74%
9. Brookfield Dental Care Launches Ground-breaking Cavity Prevention Program That Can Lower Decay Rates by 74%
10. Elsevier Launches New Open Access Journal: Translational Proteomics
11. Project Oncology CME Series Launches on ReachMD, Offering Learners a Wide Array of Certified Oncology Activities Across an Integrated Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , ... February 23, 2017 ... ... announced today that in a published evaluation of multiple immunoassay-based threat detection ... Department of Energy Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found ...
(Date:2/23/2017)... ... February 23, 2017 , ... Today, ... cortisol, CRP, adiponectin, uric acid, and/or other biomarkers or SNPs of interest) using ... Salimetrics’ SalivaLab , the relationship between insulin and other relevant biomarkers can ...
(Date:2/23/2017)... LOS ANGELES , Feb. 23, 2017  Capricor Therapeutics, ... cardiac and other medical conditions, today announced that Linda Marbán, ... at two upcoming investor conferences: Cowen ... 2017 at 10:00 am ET Boston, MA ... 14, 2017 at 9:00 am PT (12:00 pm ET) ...
(Date:2/23/2017)... and SAN FRANCISCO , ... privately-held regenerative medicine company, and Beyond Type 1, a ... type 1 diabetes, today announced a grant from Beyond ... functional cure for type 1 and other insulin-requiring diabetes.  ... has been developing innovative stem cell-derived cell replacement therapies ...
Breaking Biology Technology:
(Date:2/6/2017)... Feb. 6, 2017 According to Acuity ... driving border authorities to continue to embrace biometric ... are 2143 Automated Border Control (ABC) eGates and ... at more than 163 ports of entry across ... 2016 achieving a combined CAGR of 37%. APC ...
(Date:2/2/2017)...  Central to its deep commitment to honor ... Japan Prize Foundation today announced the laureates of ... envelope in their respective fields of Life Sciences ... being recognized with the 2017 Japan Prize for ... to the advancement of science and technology, but ...
(Date:1/26/2017)... -- Acuity Market Intelligence today released the 2017 "Ten ... characterizes 2017 as a "breakout" year for biometrics ... new understanding of the potential benefits these technologies ... are often perceived as threats to privacy and ... Acuity Market intelligence. "However, taken together these technologies ...
Breaking Biology News(10 mins):